The New England journal of medicine, 2021-01, Vol.384 (2), p.117-128
- Bhatt, Deepak L
- Szarek, Michael
- Steg, P. Gabriel
- Cannon, Christopher P
- Leiter, Lawrence A
- McGuire, Darren K
- Lewis, Julia B
- Riddle, Matthew C
- Voors, Adriaan A
- Metra, Marco
- Lund, Lars H
- Komajda, Michel
- Testani, Jeffrey M
- Wilcox, Christopher S
- Ponikowski, Piotr
- Lopes, Renato D
- Verma, Subodh
- Lapuerta, Pablo
- Pitt, Bertram
2021
Details
- Autor(en) / Beteiligte
- Bhatt, Deepak L
- Szarek, Michael
- Steg, P. Gabriel
- Cannon, Christopher P
- Leiter, Lawrence A
- McGuire, Darren K
- Lewis, Julia B
- Riddle, Matthew C
- Voors, Adriaan A
- Metra, Marco
- Lund, Lars H
- Komajda, Michel
- Testani, Jeffrey M
- Wilcox, Christopher S
- Ponikowski, Piotr
- Lopes, Renato D
- Verma, Subodh
- Lapuerta, Pablo
- Pitt, Bertram
- Titel
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- Ist Teil von
- The New England journal of medicine, 2021-01, Vol.384 (2), p.117-128
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- Patients with diabetes and recent worsening heart failure that had led to hospitalization were randomly assigned to receive sotagliflozin or placebo. At a median of 9 months, the total number of deaths from cardiovascular causes and hospitalizations and urgent visits for heart failure was significantly lower with sotagliflozin than with placebo.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2030183Titel-ID: cdi_swepub_primary_oai_prod_swepub_kib_ki_se_145772735
- Format
- –
- Schlagworte
- Acute Kidney Injury - chemically induced, Aged, Cardiac arrhythmia, Cardiovascular Diseases - epidemiology, Cardiovascular Diseases - mortality, Comorbidity, Congestive heart failure, Corporate sponsorship, Death, Diabetes, Diabetes mellitus (non-insulin dependent), Diabetes Mellitus, Type 2 - complications, Diabetes Mellitus, Type 2 - drug therapy, Diarrhea, Diuretics, Double-Blind Method, Drug therapy, Ejection fraction, Female, Glucose, Glycosides - adverse effects, Glycosides - therapeutic use, Heart failure, Heart Failure - complications, Heart Failure - drug therapy, Hospitalization, Hospitalization - statistics & numerical data, Humans, Hypoglycemia, Hypoglycemic agents, Hypotension, Hypotension - chemically induced, Male, Medicin och hälsovetenskap, Middle Aged, Patient outcomes, Peptides, Placebos, Sodium-glucose cotransporter, Sodium-Glucose Transporter 1 - antagonists & inhibitors, Sodium-Glucose Transporter 2 Inhibitors - adverse effects, Sodium-Glucose Transporter 2 Inhibitors - therapeutic use, Statistical analysis, Testing